Current genome-wide association studies do not yet capture sufficient diversity in
populations and scope of phenotypes. To expand an atlas of genetic associations in non-European …

Previous genome-wide association studies (GWASs) of stroke — the second leading cause
of death worldwide — were conducted predominantly in populations of European ancestry 1 …

Biobanks facilitate genome-wide association studies (GWASs), which have mapped genomic
loci across a range of human diseases and traits. However, most biobanks are primarily …

Meta-analysis is pervasively used to combine multiple genome-wide association studies (GWASs).
Fine-mapping of meta-analysis studies is typically performed as in a single-cohort …

Perivascular space (PVS) burden is an emerging, poorly understood, magnetic resonance
imaging marker of cerebral small vessel disease, a leading cause of stroke and dementia. …

Polygenic risk scores (PRSs) have been widely explored in precision medicine. However,
few studies have thoroughly investigated their best practices in global populations across …

The prediction of disease risks is an essential part of personalized medicine, which includes
early disease detection, prevention, and intervention. The polygenic risk score (PRS) has …

Genomics-driven drug discovery is indispensable for accelerating the development of novel
therapeutic targets. However, the drug discovery framework based on evidence from …

Approaches toward new therapeutics using disease genomics, such as genome-wide
association study (GWAS), are anticipated. Here, we developed Trans-Phar [integration of …

Assortative mating (AM) is a pattern characterized by phenotypic similarities between
mating partners. Detecting the evidence of AM has been challenging due to the lack of large-scale …